Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
Titel:
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
Auteur:
Yang, J.C.-H. Sequist, L.V. Zhou, C. Schuler, M. Geater, S.L. Mok, T. Hu, C.-P. Yamamoto, N. Feng, J. O'Byrne, K. Lu, S. Hirsh, V. Huang, Y. Sebastian, M. Okamoto, I. Dickgreber, N. Shah, R. Märten, A. Massey, D. Wind, S. Wu, Y.-L.